Susceptibility to patterns of ciprofloxacin among nalidixic acid-resistant Salmonella isolates collected in Banepa, Nepal from enteric fever patients


Submitted: September 21, 2015
Accepted: September 15, 2016
Published: December 20, 2016
Abstract Views: 1254
PDF: 756
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Girija Roka Department of Microbiology, National College, Kathmandu, Nepal.
  • Subash Pandaya Department of Pharmacy, North South University, Dhaka, Bangladesh.
  • Md. Reyad-ul Ferdous Department of Pharmacy, North South University, Dhaka; Department of Pharmacy, Progati Medical Institute, Dhaka, Bangladesh.
  • Manson Pandey Department of Pharmaceutical Sciences, Sardar Bhagwan Singh Post-graduate Institute of Biomedical Sciences and Research, Deheradun, India.
  • Naba Raj Pokhrel Department of Microbiology, National College, Kathmandu, Nepal.
  • Rashmi Shrestha Scheer Memorial Hospital, Banepa, Nepal.
  • Tamara Towshin Alam Department of Pharmacy, North South University, Dhaka, Bangladesh.
  • Md. Mustahsan Billah Department of Pharmacy, Dhaka International University, Dhaka; Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh.
  • Sayed Koushik Ahamed Department of Pharmacy, Comilla University, Comilla, Bangladesh.
The present study determined the susceptibility to ciprofloxacin of nalidixic acid resistant Salmonella (NARS) isolated from enteric fever patients at Scheer Memorial Hospital, Banepa, Nepal, from June 2012 to December 2012. The antimicrobial sensitivity to nalidixic acid and ciprofloxacin was determined using modified Kirby-Bauer disc diffusion and broth dilution method according to the guidelines of the Clinical and Laboratory Standard Institute. Salmonella was isolated from 34 out of 992 (3.43%) blood cultures collected during the study period, and 10 (29.4%) isolates were identified as Salmonella enterica serotype Typhi, while 24 (70.6%) were identified as Salmonella enterica serotype Paratyphi. Out of the total isolates, 31 (91.2%) were nalidixic acid-resistant Salmonella (NARS). Among NARS, the minimum inhibitory concentration values for ciprofloxacin ranged from 0.25 to 2 mg/L and were constantly higher than those shown by the nalidixic acid-susceptible Salmonella. Therefore, in typhoid Salmonella nalidixic acid resistance may be the indicator of decreased susceptibility to ciprofloxacin.

Girija Roka, Department of Microbiology, National College, Kathmandu
Lecturer, Dept. of Pharmacy
Roka, G., Pandaya, S., Ferdous, M. R.- ul, Pandey, M., Pokhrel, N. R., Shrestha, R., Alam, T. T., Billah, M. M., & Ahamed, S. K. (2016). Susceptibility to patterns of ciprofloxacin among nalidixic acid-resistant Salmonella isolates collected in Banepa, Nepal from enteric fever patients. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 89(2). https://doi.org/10.4081/jbr.2016.5527

Downloads

Download data is not yet available.

Citations